SMPD1 and COVID-19: Therefore, the C16:0-ceramide elevations in COVID-19 plasma may reflect endothelial cell ASMase activation by oxidative stress (38), inflammatory cytokines (39), or excess angiotensin II (40) that characterize severe SARS-CoV-2 infection (41, 42).